Connect with us

Health

US Donates Fresh 2.5 million Pfizer Vaccine to Nigeria

Published

on

COVAX Pfizer Vaccines

By Adedapo Adesanya

The United States has announced the donation of 2.5 million Pfizer vaccine doses to Nigeria.

This was disclosed in a statement by the U.S Embassy on Thursday.

According to the statement, the vaccine doses arrived in Abuja this week and were received by the National Primary Health Care Development Agency (NPHCDA) and taken to cold storage in preparation for distribution.

The vaccines are planned to be distributed to over 3,000 health facilities across all 36 states and the Federal Capital Territory, Abuja.

The statement added that the vaccines in the next few weeks will be available across major locations for vaccination in the country.

“Over the next several weeks, the vaccines will be available at major markets, shopping malls, event centers, motor parks, airports, places of employment, and religious institutions as part of Nigeria’s mass vaccination campaign.”

The statement added that, “the United States has donated more than 13.5 million doses of COVID-19 vaccine in partnership with COVAX, or bilaterally to Nigeria.

“Additionally, the United States has provided more than $119 million in COVID-19 related health assistance.”

The COVID-19 related health assistance according to the U.S Embassy includes a 40-bed mobile field hospital, ventilators, and related training for 88 hospitals, personal protective equipment, technical assistance for vaccine readiness, risk communication, and demand generation for vaccines.

Others include “conducting an epidemiological COVID-19 detection and vaccine hesitancy survey, setting up electronic record systems, rapid response teams, training for over 200,000 military and civilian personnel on COVID-19 control measures, and technology for virtual training.”

In addition, the United States leveraged the PEPFAR-supported National Integrated Specimen Referral Network (NiSRN) and laboratory investments to support the expansion of the NCDC (153) molecular laboratory network nationwide.

The statement explained that the United States is committed to helping end the pandemic in Nigeria and everywhere, also committed to donating more than one billion vaccine doses around the world, by early 2022.

This includes African countries primarily through the COVAX initiative. Improving equitable distribution remains a priority for the United States to prevent the emergence of new variants that threaten populations everywhere.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Continue Reading
1 Comment

1 Comment

  1. Pingback: US Donates Fresh 2.5 million Pfizer Vaccine to Nigeria - Daily Jagaban

Leave a Reply

Health

WHO Partners Health Authorities to Bolster Monkeypox Testing in Africa

Published

on

Monkeypox

By Adedapo Adesanya

The World Health Organisation (WHO) has announced that it was working with national health authorities in Africa to bolster surveillance and laboratory diagnosis to detect cases and deter a silent spread of the virus.

The continent as of June 28 has reported 1,821 cases in 13 countries of which 109 are laboratory confirmed in nine countries. The number of confirmed cases accounts for 2 per cent of the more than 4,500 confirmed cases globally.

However, there are a large number of suspected cases in the region, 81 per cent of which are in the Democratic Republic of the Congo, underlining the need for increased diagnostic capacity.

While all African countries have the polymerase chain reaction machines needed to test for monkeypox thanks to reinforced laboratory capacity in the wake of COVID-19, many lack reagents and in some cases training in specimen collection, handling and testing.

As a result, WHO is working to secure 60,000 tests for Africa, with around 2,000 tests and reagents to be shipped to high-risk countries and 1,000 to those facing lower risk.

Over the past months, five more African countries have received donations of reagents from partners, bringing to 12 the number of countries in the region with enhanced monkeypox diagnostic capacity. Another group of countries in West Africa will receive reagents after participating in a training.

Outside the six countries in Africa with a history of human transmission, monkeypox has also been reported in three countries which have not previously had any human cases. These include Ghana, Morocco and South Africa, which have confirmed the disease in two patients with no travel history, suggesting there is a high possibility of local transmission.

“The geographic spread of monkeypox to parts of Africa where cases have never been detected before is a worrying sign,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “It is critical that we support national efforts to boost surveillance and laboratory diagnosis, which are the cornerstones of disease control.”

To deepen the analysis of monkeypox transmission patterns, WHO is supporting countries to capitalize on the improved genomic sequencing capacity built during the COVID-19 pandemic.

Many years of research have led to the development of new and safer (second- and third-generation) vaccines for smallpox, some of which may be useful for monkeypox and one of which (MVA-BN) has been approved for the prevention of monkeypox. However, supplies are limited.

“What happened in the early days of the COVID-19 vaccine rollout when Africa watched on the sidelines as other countries snapped up limited supplies must not be allowed to recur. There are some signs that this is already happening,” said Dr Moeti. “The current global spotlight on monkeypox should be a catalyst to beat this disease once and for all in Africa. For this, we know vaccines are a critical tool.”

WHO is also working closely with the Member States and partners to define what type of coordination mechanism could be put in place to ensure fair access to vaccines. There are many regulatory, legal, operational, technical, and other issues to clarify before an allocation mechanism is fully operational.

With limited vaccines and antivirals, WHO does not recommend mass vaccination for monkeypox but rather targeted vaccination for people who have been exposed or are at high risk including health workers, laboratory personnel and outbreak team responders.

Continue Reading

Health

African Health Scientists Attend Monkeypox Virus Workshop

Published

on

Monkeypox virus workshop

By Kestér Kenn Klomegâh

With rising cases of Monkeypox virus in Africa, the Centre for Disease Control (Africa CDC) and the African Society for Laboratory Medicine (ASLM) have jointly held their first training on Real-Time PCR-based Monkeypox virus (MPXV) testing for 20 African Union Member States in Abuja, Nigeria.

It was the first in the series of hands-on training on real-time PCR-based monkeypox virus (MPXV) diagnosis launched and organized in partnership with the Nigeria Centre for Disease Control (NCDC) in June.

The three-day training workshop is designed to cover a combination of theoretical and hands-on training in the collection and handling of MPXV suspected specimens; isolation of nucleic acid; detection of MPXV using RT-PCR assay; interpretation and reporting of results for public health interventions.

Furthermore, the Africa CDC in partnership with Jiangsu Bioperfectus Technologies Co., Ltd. will distribute MPXV RT-PCR kits to expand testing in participating Member States.

Dr Yenew Kebede, Head Division of Laboratory Systems and Networks at the Africa CDC, said: “Laboratory testing capacity is key to expanding MPXV surveillance in endemic and non-endemic countries across the continent. This training is timely and critical to building and expanding MPXV testing capacity and capability across the continent. We will continue to organize additional trainings and distribute testing kits to the additional African Member States in order to strengthen MPXV surveillance in the continent.”

Dr Ifedayo Adetifa, Director General of NCDC, commented: “Establishing diagnostic capacity for infectious diseases including for monkeypox virus is an essential first step in gaining the understanding required for preparedness and response. So, we are very delighted to partner with Africa CDC to conduct hands-on training for 20 African countries on the RT-PCR-based detection of the monkeypox virus. The training covers a range of topics from collection and handling of the specimen to RT-PCR testing and reporting of results to inform response and containment strategies.”

Dr Ahmed Ogwell, Acting Director of the Africa CDC, said: “Africa CDC will continue to support the Member States in strengthening their capacity and capability to detect and respond to disease outbreaks. Recently, we have issued a call for more support to the Member States and increased access to diagnostics, therapeutics and vaccines to limit the spread of MPXV. The MPXV training and the distribution of test kits are key to expanding MPXV surveillance across the continent.”

The participants are expected to put into practice the skills and knowledge gained from this training to expand MPXV testing and surveillance in their home country. Furthermore, the training workshop will create a network of laboratory experts to collaborate and share expertise and resources in MPXV detection and response.

The training was coordinated and supported through the Africa CDC – Africa Pathogen Genomics Initiative (Africa PGI). The training workshop targeted 20 participants from 20 African Union (AU) Member States: Benin, Chad, Cote d’Ivoire, Democratic Republic of Congo, Ethiopia, Gabon, Ghana, Guinéa, Liberia, Mali, Mozambique, Niger, Republic of Congo, Senegal, Sierra Leone, South Sudan, Sudan, Togo, Uganda, and Zambia.

Continue Reading

Health

Sterling Bank, NHEA Honour Exceptional Healthcare Providers

Published

on

Sterling Bank healthcare providers

By Aduragbemi Omiyale

Some healthcare providers who were exceptional during the COVID-19 pandemic have been honoured at the Nigeria Healthcare Excellence Awards (NHEA) with support from Sterling Bank Plc.

At the 8th annual event held in Lagos over the weekend, special recognition awards were given to Medbury Medical Services as the Most Responsive COVID-19 Testing Company of the Year and Seven-UP Bottling Company Plc as the Most Outstanding COVID-19 Consumables Manufacturer of the Year. Other recipients were the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemers University in Ede, Osun State as the Most Outstanding Genomics Laboratory of the Year and Nassarawa State as the Most Outstanding State for COVID-19 Vaccination.

Speaking on the occasion themed Innovative Healthcare Services in the Era of Change, the Group Head of Health Finance at Sterling Bank, Ms Ibironke Akinmade, explained that the bank recognised and honoured the champions of the COVID-19 pandemic because of the excellent services they rendered while the pandemic was raging in a bid to spur them to do more.

“Sterling Bank is committed to improving access to healthcare for every Nigerian and our flagship offering – digitisation of State Health Insurance Platform – prefers 360-degree solution to help states bring healthcare to every citizen as well as provide a wealth of data to inform policies, planning and strategy, at no initial investment,” she said.

The Divisional Head of Business Growth and Transaction Banking at Sterling Bank, Mr Obinna Ukachukwu, while speaking at the event, had observed that the lender recognised the role that NHEA is playing in the health sector by rewarding excellence and promoting positive outcomes in the sector.

He noted that Sterling Bank, a leading player in the financing of the health sector, decided to come on board to further support the excellence and growth of the sector.

On his part, the Minister of Health, Mr Ehanire Osagie, who was represented by the Managing Director of the Federal Medical Centre, Yaba, Lagos, Dr Adedamola Dada, commended the organisers of the awards and remarked that the purpose of recognising and rewarding healthcare professionals that contributed to efficient and quality healthcare services is to foster excellence and sustain the quality.

“Good healthcare delivery is a key objective of this present administration,” he declared.

Chairman of the Advisory Board of NHEA, Dr Anthony Omolola, while speaking said, “Over the years, NHEA has continued to strive to deliver new and creative ways to honour excellence across the healthcare space. This year’s is not different at all. At these awards, we are paying attention to those who pioneered innovative healthcare services in the era of change.”

NHEA Executive Secretary, Ms Vivian Alkali, expressed the confidence that with Sterling Bank’s partnership and support, subsequent editions of NHEA will meet with greater success.

NHEA is an initiative of Global Health Projects and Resources in collaboration with Anadach Group of the United States of America. It is a yearly event where individuals and organisations are recognised and celebrated for their exceptional contributions to the healthcare sector.

The initiative, through its eminent team’s research and innovation, has continued to encourage improvements and focus on the quality and standard of service provided by various stakeholders in the industry.

Continue Reading

Latest News on Business Post

Like Our Facebook Page

%d bloggers like this: